Neurokinin-1 Receptor Antagonists

Known as: Receptor Blockers, Neuroleukin-1, Receptor Antagonists, Neurokinin-1, Neurokinin 1 Receptor Antagonists 
Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2014
Review
2014
The tachykinins, exemplified by substance P, are one of the most intensively studied neuropeptide families. They comprise a… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Osteosarcoma is a highly malignant bone tumor in children and adolescents. Aprepitant is a selective high‑affinity antagonist of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2013
Review
2013
INTRODUCTION The substance P (SP)/neurokinin (NK)-1 receptor system is involved in many pathological processes. NK-1 receptor… (More)
  • table 1
  • table 2
Is this relevant?
2011
2011
A screening of conformationally constrained aromatic amino acids as base cores for the preparation of new NK1 receptor… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • table 1
Is this relevant?
2008
2008
Several studies have suggested that neurokinin-1 (NK1) receptor antagonists may have therapeutic potential as novel… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2007
Review
2007
Overactive bladder (OAB) is a syndrome characterized by urinary urgency, with or without urgency urinary incontinence, usually… (More)
Is this relevant?
2007
2007
Based upon animal experiments and early clinical trials, neurokinin-1 receptor antagonists showed promise as novel… (More)
Is this relevant?
2007
2007
BACKGROUND Neurokinins (e.g., substance P) contribute to pain transmission in the central nervous system, peripheral neurogenic… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2003
2003
Previously, we have shown that primary afferent sensory neurons are necessary for disease activity in T cell-mediated immune… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
1995
1995
Octreotide, a somatostatin analogue that inhibits the release of most gut peptides, hastens the resolution of experimental… (More)
Is this relevant?